Alveus Therapeutics
FranceEntry
2026
Hold
New
Status
Active
Who owns Alveus Therapeutics?
Alveus Therapeutics is a French Biotech company, currently owned by Andera Partners since 2026 and Jeito Capital.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Ownership history
2 ownership periods
Active
Andera PartnersActive
2026 · present(<1yr) · BioDiscovery 7 · 2025 · VC
Jeito CapitalActive
2026 · present(<1yr) · Jeito II · 2026 · VC
More from Jeito II
Other portfolio companies in the same fund.
Denmark
Belgium
Netherlands
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Alveus Therapeutics?
Alveus Therapeutics is currently owned by Andera Partners and Jeito Capital, through Jeito II, since 2026.
When did Andera Partners and 1 other acquire Alveus Therapeutics?
Andera Partners and 1 other acquired Alveus Therapeutics in 2026.
Who has owned Alveus Therapeutics over time?
Alveus Therapeutics has been through 2 private-equity ownership periods: Andera Partners · via BioDiscovery 7 · since 2026; Jeito Capital · via Jeito II · since 2026.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue